Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity
about
Transcriptomic effects of di-(2-ethylhexyl)-phthalate in Syrian hamster embryo cells: an important role of early cytoskeleton disturbances in carcinogenesis?Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID miceChronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cellsInhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.Therapeutic targeting of hyaluronan in the tumor stroma.Hyaluronan in cytosol--microinjection-based probing of its existence and suggested functions.The glycocalyx and its significance in human medicine.Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.The control and importance of hyaluronan synthase expression in palatogenesis.Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.Versican V1 isoform regulates cell-associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells.Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.Caution should be used in long-term treatment with oral compounds of hyaluronic acid in patients with a history of cancer.Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells.Divergent Temporal Expression of Hyaluronan Metabolizing Enzymes and Receptors with Craniotomy vs. Controlled-Cortical Impact Injury in Rat Brain: A Pilot StudyAccumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment.Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer.Suppression of hyaluronan synthesis attenuates the tumorigenicity of low-grade chondrosarcoma.
P2860
Q34057399-6037AB68-0D14-4E1B-946B-2BF10734DDFBQ34587232-A46E400C-97FD-46AE-8145-4BB02CDC6622Q34658335-FC8DCDCB-D17C-4B73-A385-FB965477DFEAQ35440662-601A4C82-10C2-4D15-817B-FC7DFA93D0B2Q35574955-63609428-09A8-432B-9567-263B1219FC27Q35653938-334124E6-299B-4011-9E8F-B7AA53E227AAQ35848212-1945ECF8-D790-48F6-8510-BA7636EA0952Q36375025-A959E12A-4274-40DC-BE62-8419AF5CE72CQ38161392-5A87685A-C8C0-4898-9A9C-87F226B5BD5DQ38320611-1BA49377-77CD-45EC-9D9D-489CFB91F85EQ38691530-C39451F4-71BE-4EED-856F-07A0FE032ABBQ38740401-254D7D3A-D79B-4005-92C2-0810AFA2ED79Q38796290-C98D1CA9-A485-46E3-BBC1-3085D31DE874Q39023950-EE9FB1D4-F577-40AA-B758-7A2AC3DA9DECQ39369826-1FD14252-2D01-44B8-8147-A5BB83A0768AQ39472524-B748031C-728E-464C-94A2-8388E0DF5FADQ39474674-82A4EA18-8286-49F8-92FB-B56B9469081AQ39524896-36B6F793-653A-4AE9-B471-43FBC9C7C657Q39579117-64A23294-3743-470B-B137-2304029543B0Q40496192-FC7E6FF4-A892-478F-A995-69D3DEF5FC14Q41695202-3121F145-295C-4377-B3E7-D1DD1221B048Q41843755-5BC8E6DF-645C-4CFF-9BB9-BC1B20F510D5Q42137561-7E22A435-A0E4-4CFA-8DAF-4D81835AB011Q42181013-DE8CCA1B-0191-46F3-A362-71FE92F5F2B1Q46557742-6FA97066-1CF9-4A31-9245-B83C0275C276Q47392155-CE8D4228-B0F0-4D68-A1A1-C6D7775CFFCE
P2860
Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@ast
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@en
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@nl
type
label
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@ast
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@en
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@nl
prefLabel
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@ast
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@en
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@nl
P2093
P2860
P1476
Antisense inhibition of hyalur ...... n retention and tumorigenicity
@en
P2093
Cheryl B Knudson
Naoki Ishiguro
Warren Knudson
Yoshihiro Nishida
P2860
P304
P356
10.1016/J.YEXCR.2005.03.026
P407
P577
2005-07-01T00:00:00Z